Design and analysis of nested case–control studies for recurrent events subject to a terminal event. (9th July 2019)

• Record Type: Journal Article
• Authors: Jazić, Ina; Haneuse, Sebastien; French, Benjamin; MacGrogan, Gaëtan; Rondeau, Virginie
• Is Part Of: Statistics in medicine. Volume 38:Number 22(2019)
• Page Start: 4348
• Page End: 4362
• Publication Date: 2019-07-09
• Subjects: joint frailty models -- nested case–control studies -- penalized likelihood -- recurrent events; Medical statistics -- Periodicals; Statistique médicale -- Périodiques; Statistiques médicales -- Périodiques; 610.727
• DOI: 10.1002/sim.8302
• Languages: English
• ISSNs: 0277-6715

Abstract

Abstract : The process by which patients experience a series of recurrent events, such as hospitalizations, may be subject to death. In cohort studies, one strategy for analyzing such data is to fit a joint frailty model for the intensities of the recurrent event and death, which estimates covariate effects on the two event types while accounting for their dependence. When certain covariates are difficult to obtain, however, researchers may only have the resources to subsample patients on whom to collect complete data: one way is using the nested case–control (NCC) design, in which risk set sampling is performed based on a single outcome. We develop a general framework for the design of NCC studies in the presence of recurrent and terminal events and propose estimation and inference for a joint frailty model for recurrence and death using data arising from such studies. We propose a maximum weighted penalized likelihood approach using flexible spline models for the baseline intensity functions. Two standard error estimators are proposed: a sandwich estimator and a perturbation resampling procedure. We investigate operating characteristics of our estimators as well as design considerations via a simulation study and illustrate our methods using two studies: one on recurrent cardiac hospitalizations in patients with heart failure and the other on local recurrence and metastasis in patients with breast cancer.